Flexion Therapeutics (FLXN) Misses Q2 EPS by 4c

Flexion Therapeutics (NASDAQ: FLXN) reported Q2 EPS of ($0.58), $0.04 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Flexion Therapeutics (FLXN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49